Your browser doesn't support javascript.
loading
Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer.
Montero, Juan Carlos; Calvo-Jiménez, Elisa; Del Carmen, Sofía; Abad, Mar; Ocaña, Alberto; Pandiella, Atanasio.
Afiliação
  • Montero JC; Institute of Biomedical Research of Salamanca (IBSAL), Instituto de Biología Molecular y Celular del Cáncer (CSIC-Universidad de Salamanca) and CIBERONC, Salamanca, Spain. jcmon@usal.es.
  • Calvo-Jiménez E; Department of Pathology and IBSAL, University Hospital of Salamanca, University of Salamanca, 37007, Salamanca, Spain. jcmon@usal.es.
  • Del Carmen S; Institute of Biomedical Research of Salamanca (IBSAL), Instituto de Biología Molecular y Celular del Cáncer (CSIC-Universidad de Salamanca) and CIBERONC, Salamanca, Spain.
  • Abad M; Department of Pathology and IBSAL, University Hospital of Salamanca, University of Salamanca, 37007, Salamanca, Spain.
  • Ocaña A; Department of Pathology and IBSAL, University Hospital of Salamanca, University of Salamanca, 37007, Salamanca, Spain.
  • Pandiella A; Symphogen, Copenhagen, Denmark.
J Exp Clin Cancer Res ; 41(1): 106, 2022 Mar 22.
Article em En | MEDLINE | ID: mdl-35317825
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoconjugados / Cadeia Pesada da Proteína-1 Reguladora de Fusão / Neoplasias de Mama Triplo Negativas Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoconjugados / Cadeia Pesada da Proteína-1 Reguladora de Fusão / Neoplasias de Mama Triplo Negativas Idioma: En Ano de publicação: 2022 Tipo de documento: Article